Form 4: EBR Systems Director Receives Stock Option Grant

Director Christopher Nave was granted 34,211 stock options in EBR Systems, Inc. as part of a standard equity compensation plan.

Summary

• Director Christopher Nave received a grant of 34,211 stock options on May 6, 2026.
• The options have an exercise price of $3.7999 per share.
• The options are set to expire on May 5, 2036.
• Vesting occurs in 1/12 increments monthly, beginning June 6, 2026, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential for future dilution of existing shareholders upon the exercise of these options.

Risks

• Vesting is subject to the director remaining a service provider to the company.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on the disclosure of director equity compensation.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term oversight and strategic alignment in the medical technology sector.

Comparison to Industry Standards

• The grant structure follows standard industry practices for non-employee director compensation packages.
• Monthly vesting schedules are common in the technology and biotech sectors to ensure ongoing commitment.

Corporate Governance

Stakeholder Impact

• Shareholders may experience minor dilution if options are exercised in the future.

Next Steps

• Director to begin vesting of options on June 6, 2026.

Key Dates

Keywords

EBR Systems, Form 4, Director Compensation, Stock Options, Insider Transaction